Similar Efficacy Between Atezolizumab Plus Bevacizumab Versus Hepatic Arterial Infusion Chemotherapy For Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Retrospective Cohort Study

AKIFUMI KUWANO; MASAYOSHI YADA; KOSUKE TANAKA; YUTA KOGA; SHIGEHIRO NAGASAWA; AKIHIDE MASUMOTO; KENTA MOTOMURA

doi:10.21873/invivo.13639

Article Information

vol. 38 no. 4 1854-1858

DOI

https://doi.org/10.21873/invivo.13639

PMID

38936922

Published By

International Institute of Anticancer Research

Print ISSN

0258-851X

Online ISSN

1791-7549

History

Received February 22, 2024
Revision received March 26, 2024
Accepted April 5, 2024
Published online June 27, 2024.

Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

AKIFUMI KUWANO,
MASAYOSHI YADA ⇑,
KOSUKE TANAKA,
YUTA KOGA,
SHIGEHIRO NAGASAWA,
AKIHIDE MASUMOTO and
KENTA MOTOMURA

Department of Hepatology, Aso Iizuka Hospital, Fukuoka, Japan

Correspondence to: Masayoshi Yada, MD, Ph.D., Department of Hepatology, Aso Iizuka Hospital, 3-83 Yoshio-machi, Iizuka, Fukuoka 820-8505, Japan. Tel: +81 948223800, Fax: +81 948295744, e-mail: myadah1{at}aih-net.com

View Full Text